BUY IPCA Laboratories LimitedIDBI Capital

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,995Stated
Target₹2,140
Stop loss₹1,937-2.91% risk
CMP₹1,975.2Just now
Active-0.99%+8.34%upside left 13d left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 17 Sept, 3:21 pm IST
4 supporting1 opposing
Supports the BUY call (4)

Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits

NewsGoogle News·16 Sept · today

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·16 Sept · yesterday

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Sept · 1w ago

Krebs Biochemicals భారీ నష్టం.. Ipca Labs తో విలీనానికి గ్రీన్ సిగ్నల్!

NewsGoogle News·4 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·17 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.